|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
11736849 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
180711s2018 sz a ob 001 0 eng d |
| 005 |
20240510213348.8 |
| 016 |
7 |
|
|a 019138596
|2 Uk
|
| 019 |
|
|
|a 1043870983
|a 1050973658
|a 1081215708
|a 1103254197
|a 1105188428
|
| 020 |
|
|
|a 9783319772585
|q (electronic bk.)
|
| 020 |
|
|
|a 3319772589
|q (electronic bk.)
|
| 020 |
|
|
|z 9783319772578
|
| 020 |
|
|
|z 3319772570
|
| 020 |
|
|
|a 9783319772592
|q (print)
|
| 020 |
|
|
|a 3319772597
|
| 020 |
|
|
|a 9783030084127
|q (print)
|
| 020 |
|
|
|a 3030084124
|
| 024 |
7 |
|
|a 10.1007/978-3-319-77258-5
|2 doi
|
| 024 |
8 |
|
|a 10.1007/978-3-319-77
|
| 035 |
|
|
|a (OCoLC)1043830975
|z (OCoLC)1043870983
|z (OCoLC)1050973658
|z (OCoLC)1081215708
|z (OCoLC)1103254197
|z (OCoLC)1105188428
|
| 035 |
|
9 |
|a (OCLCCM-CC)1043830975
|
| 037 |
|
|
|a com.springer.onix.9783319772585
|b Springer Nature
|
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d GW5XE
|d YDX
|d OCLCF
|d EBLCP
|d UKMGB
|d VT2
|d CNCEN
|d WYU
|d OCLCQ
|d UAB
|d MERER
|d OCLCQ
|d COO
|d UKAHL
|d LQU
|d OCLCQ
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a RC157
|
| 066 |
|
|
|c (S
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 072 |
|
7 |
|a MJCM
|2 bicssc
|
| 072 |
|
7 |
|a MJCM
|2 thema
|
| 245 |
0 |
0 |
|a Complement activation in malaria immunity and pathogenesis /
|c José A. Stoute, editor.
|
| 264 |
|
1 |
|a Cham, Switzerland :
|b Springer,
|c [2018]
|
| 300 |
|
|
|a 1 online resource :
|b color illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Online resource; title from PDF title page (EBSCO, viewed July 13, 2018).
|
| 505 |
0 |
|
|6 880-01
|a Intro; Dedication; Preface; Contents; Contributors; The Complement System; Introduction; Classical Pathway; Lectin Pathway; Alternative Pathway; Terminal Complement Activation; Extrinsic Complement Activation Pathways; Anaphylatoxins; Complement Regulators; Soluble Complement Regulators; Surface-Bound Complement Regulators; Complement Receptors; References; Mechanisms of Complement Activation in Malaria; Introduction; Malaria Biology; Measures of Complement Activation; Immune Complexes Activate the CP of Complement.
|
| 505 |
8 |
|
|a Complement and Malaria/Cerebral MalariaComplement in Murine Models of Cerebral Malaria; Complement Gene-Targeted and Transgenic Mice in ECM; Classical Pathway; Lectin Pathway; Alternative Pathway; Anaphylatoxin Receptors and Anaphylatoxins; C3 and C5; Terminal Pathway; Complement Phagocytic Receptors and Regulatory Proteins; Integrating the Role of Complement in ECM; Complement-Mediated Therapeutic Approaches to Cerebral Malaria; References; Complement and Malaria in Pregnancy; Global Burden of Malaria Infection During Pregnancy; Pathophysiology of Malaria in Pregnancy.
|
| 505 |
8 |
|
|a The Role of Complement Activation in Pregnancy ComplicationsComplement Activation in Pregnancy; Complement in Non-malarial Pregnancy Pathologies; The Role of Complement Activation in Malaria in Pregnancy; Emerging Evidence of Complement Activation in MiP and Fetal Neurodevelopment; Therapeutic Potential of Targeting Complement Activation in MiP; Conclusions; References; Complement Evasion Mechanisms of the Human Pathogen Plasmodium falciparum; Merozoite Invasion into Red Blood Cells; Merozoite Surface Proteins; 6-Cysteine Family of Merozoite Surface Proteins.
|
| 520 |
|
|
|a References; Role of Complement in Severe Malarial Anemia; The Problem of Severe Malarial Anemia; Evidence of Complement Activation During Malaria; Evidence of Opsonoization and Changes in the Expression of Complement Regulatory Proteins on Uninfected Erythrocytes of Patients with Malaria; Genetic Association Studies; Directions for Future Research; References; Role of Complement in Cerebral Malaria; The Impact of Malaria/Cerebral Malaria; Clinical Features of Cerebral Malaria; Molecular Features of CM; Complement Synthesis in the Periphery and Central Nervous System.
|
| 650 |
|
0 |
|a Complement activation.
|0 http://id.loc.gov/authorities/subjects/sh92002550
|
| 650 |
|
0 |
|a Immunity.
|0 http://id.loc.gov/authorities/subjects/sh85064541
|
| 650 |
|
0 |
|a Malaria
|x Pathogenesis.
|
| 650 |
|
0 |
|a Malaria
|x Immunological aspects.
|0 http://id.loc.gov/authorities/subjects/sh85080039
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Complement activation.
|2 fast
|0 (OCoLC)fst00871564
|
| 650 |
|
7 |
|a Immunity.
|2 fast
|0 (OCoLC)fst00967888
|
| 650 |
|
7 |
|a Malaria
|x Immunological aspects.
|2 fast
|0 (OCoLC)fst01006356
|
| 650 |
|
7 |
|a Medical parasitology.
|2 bicssc
|
| 650 |
|
7 |
|a Infectious & contagious diseases.
|2 bicssc
|
| 650 |
|
7 |
|a Tropical medicine.
|2 bicssc
|
| 650 |
|
7 |
|a Medical laboratory testing & techniques.
|2 bicssc
|
| 650 |
|
7 |
|a Immunology.
|2 bicssc
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Parasitology.
|
| 650 |
2 |
4 |
|a Infectious Diseases.
|
| 650 |
2 |
4 |
|a Tropical Medicine.
|
| 650 |
2 |
4 |
|a Laboratory Medicine.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Stoute, José A.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Complement activation in malaria immunity and pathogenesis.
|d Cham, Switzerland : Springer, [2018]
|z 3319772570
|z 9783319772578
|w (OCoLC)1022789499
|
| 880 |
8 |
|
|6 505-01/(S
|a IC-mediated Complement Activation, Complement Control Proteins, and Fcγ ReceptorsComplement Is Activated by Infected E and by E Breakdown Products; Activation of the AP of Complement Can Opsonize Uninfected E with C3b: Potential Consequences; Paroxysmal Nocturnal Hemoglobinuria (PNH) as a Model for Extravascular Clearance of C3d-Opsonized E; Additional Evidence for Activation of the Alternative Pathway; Acidemia: Another Possible Activator of Complement; Complement Activation by the MBL Pathway; Changes in the Spleen Possibly Mediated by Complement During Malarial Infections: Speculations.
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i 822d215b-44ce-5f70-8f16-a50de374be37
|s 157b602d-dc0c-515a-a6f3-b1cbddd19b16
|
| 928 |
|
|
|t Library of Congress classification
|a RC157
|l Online
|c UC-FullText
|u https://link.springer.com/10.1007/978-3-319-77258-5
|z Springer Nature
|g ebooks
|i 12555725
|
